A New Paradigm in Precision Immunotherapy
An automated platform for patient-specific
monoclonal antibodies
Paradigm Shift
From conventional antibody development to scalable,
precision-driven immunotherapy platforms, powered by SAMBA.
N-of-Many
N-of-FEW
N-of-1
TRADITIONAL MEDICINE
One drug fits all
Examples:
Chemotherapy
Precision Medicine
Sequencing & molecular profiling
Biomarkers & companion diagnostics
Immunotherapy
Examples:
Anti-HER2 therapies,
CAR-T anti-CD19
PERSONALIZED
MEDICINE:
THE SAMBA ERA
Patient-specific biologics
Maximum molecular selectivity
Designed and produced
for a Single Patient.
THE PROBLEM
Science can now identify patient-specific molecular targets with unprecedented precision.
However, translating this knowledge into therapies at the individual patient level remains a major bottleneck.
While N-of-1 and highly personalized biologics are scientifically feasible, their industrial production is complex, slow, and difficult to scale, limiting real-world adoption.
THE
NEED
Healthcare systems, clinicians,
and industry require
a new manufacturing paradigm
able to support patient-specific therapies with the same rigor, reproducibility,
and traceability of traditional biologics.
This requires automation, standardization, and digital control to transform personalized therapies from exceptional cases into a sustainable
and scalable reality.
GMP Certified
Patented Technology
Approved and Published by Official Scientific Community Publication Journal
Peer Reviewed
Sustainable
Ai Powered and Automated
Designed to operate within GMP-compliant manufacturing environments, ensuring regulatory alignment and clinical-grade quality.
Core innovations are protected
by Granted Patents covering key aspects
of therapeutic development.
Scientific Foundations Validated through
peer-reviewed publications and independent
academic research
A production model Designed to make Highly personalized biologics Economically and operationally sustainable.
Advanced computational tools
support molecular analysis and process optimization.
Automation enables reproducibility,
traceability, and scalability across personalized therapeutic workflows.
Eupaxx SpA Benefit Company
Industrial Engineering partner
Novalba Therapeutics Srl
AVATAR5 N-of-1 Design
OUR PROJECTS
N-OF-FEW
AVATAR 1,2,3,4
N-OF-1
AVATAR5
OUR TEAM
Maddalena Pacelli
Coming Soon
Team of Experts
Scientific Committee From Leading Universities
_edited.jpg)
Prof. Adriano Venditti
View CV
Prof. Giovanni Antonini
View CV
Prof. Francesco Buccisano
View CV
Prof. Fabio Polticelli
View CV
GET IN TOUCH
Via di Santa Croce
in Gerusalemme 63,
00185 Rome, Italy
